Biozenta manufacturing facility meets the stringent cGMP norms prescribed by the Drug Controller (General) India, Ministry of Health and Government of India in "Revised Schedule M". With an unwavering commitment to quality, Biozenta quality policy covers all the aspects of operations, from using the best raw material to strict controls at every stage of manufacturing and packaging.

Manufacturing Excellence

Biozenta has excellent capabilities in formulation, manufacturing with special strengths in developing and supplying ready formulations for the most demanding requirements of global markets. Biozenta is one of the largest manufacturers for Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).

Biozenta has multiple manufacturing facilities and a well-established supply chain and vendor development system. Biozenta manufacturing facilities are USFDA compliant and EUGMP approvable, PICs approved, WHO-GMP certified, ISO 14001, and ISO 9001 accredited for the systems. These facilities are been regularly audited by Principal's global audit teams and repeatedly certified and upgraded against their standards.

• All types of dosage forms Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).
• Environment friendly VAHP chillers, without any wood or asbestos components.
• Duo Pass Reverse Osmosis Water System / De-mineralization Plant, Multi-stage Distillation Plant and Self-sanitizing.
• De-humidification unit and dust extraction system and each zone have separate AHU.
• Duo Pass Reverse Osmosis Water System / De-mineralization Plant, Multi-stage Distillation Plant and Self-sanitizing.
• Separation of each critical processing activity in each area to avoid cross-contamination.
• Separate and dedicated production facilities for Oncology and Other range of products.
• The conditioned air environment in each area with respect to temperature, humidity, filtration, particle count, etc.
• Separate and dedicated production facilities for B-lactam and cephalosporin dosage forms.
• The conditioned air environment in each area with respect to temperature, humidity, filtration, particle count, etc.
• Zero-discharge effluent treatment plant and distribution of material under SS reverse laminar flow.
• Optional power generation system for uninterrupted production and separate air handling units for each production department.
• It is ensured that all facilities, from design to maintenance, adhere to the highest international standards.
• Cross-contamination is avoided at any stage by quarantined production blocks with independent air systems.

Biozenta’s plant is equipped with modern high speed machines and integrated packaging lines to be cost-efficient. The widespread use of non-fill devices, collators, brevity visual inspection machines, multi-station tablet presses, FFS machines, and high-speed vial/ampoule fillers/sealers are just a few examples.